GNH USA

Europe — EMA

Nicorette Invisi Patch (Nicotine)

GNH USA supplies Nicorette Invisi Patch (Nicotine), a nicotine replacement therapy for smoking cessation. Request a quote for global supply to hospitals.

Request sourcing

1
Pack/s

What is Nicotine?

Nicotine, the active ingredient in Nicorette Invisi Patch, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. The patch delivers a steady dose of nicotine through the skin, helping to alleviate withdrawal symptoms and reduce cravings during the quitting process. It treats nicotine dependence and aids smoking cessation in adult smokers seeking to quit.

GNH USA supplies Nicorette Invisi Patch as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Products are manufactured under EU regulations and meet quality standards for safety and efficacy.

What is Nicotine used for?

Nicorette Invisi Patch, a nicotine replacement therapy, is used to manage nicotine withdrawal in individuals attempting to quit smoking.

- Smoking cessation: helps reduce cravings and withdrawal symptoms during the quitting process. - Tobacco dependence: supports gradual reduction of nicotine intake for adults. - Relapse prevention: assists in maintaining abstinence after initial cessation.

What are the side effects of Nicotine?

Common Side Effects: - Skin irritation at the application site: redness, itching, or mild rash. - Localized burning or tingling sensation on the skin. - Headache: mild to moderate intensity. - Nausea or upset stomach. - Insomnia or disturbed sleep patterns.

Serious or Rare Side Effects: - Allergic reaction: swelling, hives, or severe rash. - Dizziness or fainting episodes. - Chest pain or palpitations. - Severe skin blistering or ulceration. - Unexplained hypertension.

What precautions apply to Nicotine?

Precautions should be observed when using Nicorette Invisi Patch to ensure safe and effective use. - Cardiovascular assessment: evaluate patients with recent heart attack or uncontrolled hypertension. - Pregnancy and lactation: avoid use unless benefits outweigh potential risks; safety data are limited. - Concomitant nicotine products: do not use other nicotine replacement therapies simultaneously. - Children and pets: keep patches out of reach to prevent accidental ingestion. - Storage: Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

What does Nicotine interact with?

Nicotine patches may interact with other substances that affect nicotine metabolism or cardiovascular function.

Major Interactions (Avoid): - Concurrent use of other nicotine replacement products (gum, lozenges, inhalers) – risk of nicotine overdose. - Smoking while wearing the patch – can lead to excessive nicotine levels.

Moderate Interactions (Monitor Closely): - Monoamine oxidase inhibitors (MAOIs) – may enhance nicotine's cardiovascular effects. - Certain antihypertensive medications – nicotine can counteract blood pressure‑lowering actions. - Caffeine‑containing products – may increase nervous system stimulation.

Frequently asked questions

What is Nicorette Invisi Patch used for?+
Nicorette Invisi Patch is an over‑the‑counter nicotine replacement therapy designed to help adult smokers quit by delivering a controlled amount of nicotine through the skin, thereby reducing cravings and withdrawal symptoms during the cessation process.
How does nicotine work in the patch?+
The nicotine in the patch is absorbed transdermally into the bloodstream, where it binds to nicotinic acetylcholine receptors in the brain. This partial stimulation eases withdrawal symptoms and cravings, allowing a gradual reduction in nicotine dependence.
What is the usual dose of Nicorette Invisi Patch?+
The specific dose and duration are determined by the prescribing clinician based on the individual’s smoking history and nicotine dependence. The prescriber selects the appropriate strength and treatment schedule for each patient.
Is Nicorette Invisi Patch safe during pregnancy or breastfeeding?+
Safety data for nicotine patches in pregnancy and lactation are limited. Use is generally avoided unless the potential benefit to the mother outweighs any possible risk to the fetus or infant, and it should be discussed with a healthcare professional.
How do I order Nicorette Invisi Patch from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Nicorette Invisi Patch compare with other smoking‑cessation options?+
Compared with oral nicotine replacement products such as gum or lozenges, the patch provides a steady, once‑daily nicotine delivery, which can improve adherence and reduce the need for frequent dosing. It does not involve the oral habit component that some users find helpful with gum.
How should Nicorette Invisi Patch be stored and handled?+
Store the patches at room temperature, below 25 °C, in their original sealed pouch. Keep them away from moisture, direct heat and sunlight. Do not expose the patches to extreme temperatures, as this may affect nicotine stability.
How is Nicorette Invisi Patch applied?+
The patch is applied to clean, dry, hair‑free skin on the upper arm, chest, or back. Press firmly for several seconds to ensure good contact, then replace the patch according to the prescriber’s schedule, typically every 24 hours.
What are the most serious risks associated with Nicorette Invisi Patch?+
Serious risks include allergic reactions such as severe rash, swelling or hives, as well as cardiovascular events like chest pain, palpitations or hypertension, especially in patients with pre‑existing heart conditions.
Who should not use Nicorette Invisi Patch?+
The patch should not be used by individuals with known hypersensitivity to nicotine or patch components, those who have recently experienced a heart attack or severe cardiovascular disease, and it is generally avoided in pregnant or breastfeeding women unless advised by a physician.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Nicotine
Route
Transdermal Use
Manufacturer
Kenvue Belgium Nv
Origin
EU

Related products